Spokane, WA, and Westminster, CO – September 26, 2019 – Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to...
News
News and Insights from Our Multidisciplinary Team of Experts
New Strategic Relationship to Deliver Integrated Image Analysis for PD-L1 Testing
Spokane, WA, and Westminster, CO – September 26, 2019 – Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to...
Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
BROOMFIELD, CO - July 18, 2019 — Flagship Biosciences, the advanced tissue data services company, today announced the addition of Meredith James, HT, PMP, to its executive team as Vice President of Operations. Ms. James brings a wealth of experience gained in over 20...
Flagship Biosciences Announces Biocom Membership
Broomfield, CO – April 3, 2019 — Flagship Biosciences, the advanced tissue data services company, today announced its membership in Biocom, the association representing the California life science industry. A Flagship representative will also serve on the Biocom...
Flagship Biosciences Now Provides Tissue Data Services Via Scientist.com
Westminster, CO – April 1, 2019 — Flagship Biosciences, an advanced tissue data services company, today announced a new distribution channel for its services on Scientist.com, the world’s largest marketplace for outsourced scientific services. “Flagship is excited to...
Indivumed Partners with Flagship Biosciences
Hamburg, Germany and Westminster, CO, USA, – March 28, 2019 – Indivumed and Flagship Biosciences, Inc. are pleased to announce a partnership to expand their broad tissue-based biomarker development capabilities, as well as their clinical services to support advanced...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
PUBLICATIONS/POSTERS
CIOReview Names Flagship Company of the Year
CIOReview named Flagship Biosciences “Company of the Year,” as part of the publication’s 2018 20 Most Promising Pharma & Life Sciences Tech Solution Providers industry review. “The ease of leveraging Flagship’s powerful solution is yet another massive...
Using Artificial Intelligence to Predict Response to Immunotherapy
Key Concepts: Pathological interpretations applied to PD-L1 IHC as a response biomarker are becoming more complex, going beyond simple tumor proportion score (TPS) and requiring more complex diagnostic algorithms that evaluate the role of PDL1 expression in tumor...
Pathology AI (Artificial Intelligence)
Key takeways: Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system Pathology AI enables cost effective healthcare by testing for multiple...
EVENTS
Utilizing RNAscope in the clinic: Why you need image analysis to handle the complexity
Utilizing RNAscope in the clinic to handle complex analysis. RNAscope is rapidly becoming a solution for understanding complex biomarker challenges. The benefits and awareness of image analysis in the space of pathology have been widely discussed and rapidly growing....
Precision Patient Care: Seamless Optimization of Diagnoses, Companion Testing and Therapy Design
Technology Leads the Way to Precision Patient Care Digital transformation comes in many flavors. In pathology, it can be as simple as merely scanning pathology slides into whole slide images. However, it can also represent end-to-end digital pathology workflow...
Pathology Visions 2021
Pathology Visions 2021October 17-19, 2021Digital Pathology: The Future is Here is the theme of this year’s Digital Pathology Association annual conference, Pathology Visions 2021. #PathVisions21 featured a poster from Flagship’s CCO Meredith James on a novel approach...